Renaissance Technologies LLC cut its stake in shares of TriMas Co. (NASDAQ:TRS - Free Report) by 48.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 27,800 shares of the industrial products company's stock after selling 25,800 shares during the quarter. Renaissance Technologies LLC owned approximately 0.07% of TriMas worth $711,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also bought and sold shares of the company. Innealta Capital LLC bought a new position in TriMas during the second quarter worth $26,000. Quantbot Technologies LP boosted its stake in TriMas by 5.7% during the first quarter. Quantbot Technologies LP now owns 8,933 shares of the industrial products company's stock worth $239,000 after acquiring an additional 478 shares in the last quarter. BNP Paribas Financial Markets boosted its stake in TriMas by 79.8% during the first quarter. BNP Paribas Financial Markets now owns 20,225 shares of the industrial products company's stock worth $541,000 after acquiring an additional 8,978 shares in the last quarter. Diversified Trust Co boosted its stake in TriMas by 32.7% during the first quarter. Diversified Trust Co now owns 21,647 shares of the industrial products company's stock worth $579,000 after acquiring an additional 5,333 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its stake in TriMas by 6.6% during the first quarter. Price T Rowe Associates Inc. MD now owns 23,870 shares of the industrial products company's stock worth $639,000 after acquiring an additional 1,478 shares in the last quarter. 99.42% of the stock is owned by institutional investors.
TriMas Stock Up 0.5 %
Shares of TriMas stock traded up $0.13 during trading hours on Wednesday, reaching $25.21. The company's stock had a trading volume of 284,081 shares, compared to its average volume of 253,263. TriMas Co. has a one year low of $22.45 and a one year high of $27.89. The company has a market capitalization of $1.02 billion, a P/E ratio of 25.99 and a beta of 0.67. The stock's fifty day simple moving average is $24.65 and its two-hundred day simple moving average is $25.68. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.48 and a current ratio of 2.82.
TriMas (NASDAQ:TRS - Get Free Report) last released its quarterly earnings data on Tuesday, July 30th. The industrial products company reported $0.43 earnings per share for the quarter, missing analysts' consensus estimates of $0.53 by ($0.10). TriMas had a net margin of 4.44% and a return on equity of 9.61%. The business had revenue of $240.50 million during the quarter, compared to the consensus estimate of $238.63 million. During the same period last year, the business posted $0.50 earnings per share. The firm's quarterly revenue was up 3.1% on a year-over-year basis. On average, research analysts forecast that TriMas Co. will post 1.76 earnings per share for the current year.
TriMas Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, August 13th. Investors of record on Tuesday, August 6th were given a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.63%. The ex-dividend date of this dividend was Tuesday, August 6th. TriMas's payout ratio is currently 16.49%.
Analyst Ratings Changes
Separately, BWS Financial reaffirmed a "buy" rating and issued a $40.00 price objective on shares of TriMas in a research note on Wednesday.
Get Our Latest Analysis on TRS
TriMas Company Profile
(
Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Featured Articles
Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.